Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:56AM ET
6.72
Dollar change
-0.01
Percentage change
-0.22
%
IndexRUT P/E- EPS (ttm)-0.13 Insider Own3.73% Shs Outstand226.06M Perf Week8.64%
Market Cap1.53B Forward P/E13.45 EPS next Y0.50 Insider Trans-14.98% Shs Float219.71M Perf Month25.00%
Income-28.24M PEG- EPS next Q0.06 Inst Own74.28% Short Float3.64% Perf Quarter49.78%
Sales258.21M P/S5.94 EPS this Y326.92% Inst Trans7.41% Short Ratio2.90 Perf Half Y87.33%
Book/sh0.60 P/B11.24 EPS next Y69.49% ROA-8.33% Short Interest7.99M Perf Year109.50%
Cash/sh0.23 P/C29.89 EPS next 5Y- ROE-19.67% 52W Range3.06 - 6.75 Perf YTD48.78%
Dividend Est.- P/FCF380.84 EPS past 5Y38.68% ROI-10.25% 52W High-0.37% Beta0.46
Dividend TTM- Quick Ratio1.69 Sales past 5Y73.26% Gross Margin34.16% 52W Low119.77% ATR (14)0.23
Dividend Ex-Date- Current Ratio5.16 EPS Y/Y TTM62.29% Oper. Margin8.38% RSI (14)72.29 Volatility3.64% 4.38%
Employees624 Debt/Eq1.05 Sales Y/Y TTM67.59% Profit Margin-10.94% Recom1.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq1.04 EPS Q/Q-29.52% Payout- Rel Volume0.59 Prev Close6.74
Sales Surprise2.47% EPS Surprise-420.00% Sales Q/Q47.86% EarningsFeb 28 AMC Avg Volume2.76M Price6.72
SMA2010.02% SMA5020.42% SMA20057.03% Trades Volume183,826 Change-0.22%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Resumed Raymond James Strong Buy $5
Oct-13-22Initiated Mizuho Buy $5
Nov-11-21Upgrade Raymond James Outperform → Strong Buy $5
Nov-09-21Initiated Cantor Fitzgerald Overweight $4.50
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Mar-22-24 05:50PM
Mar-20-24 08:50AM
Mar-18-24 09:55AM
09:30AM
Mar-15-24 05:50PM
07:00AM Loading…
Mar-11-24 07:00AM
Mar-05-24 12:00PM
07:00AM
Mar-04-24 08:50AM
Mar-01-24 09:55AM
09:30AM
Feb-29-24 11:06AM
10:37AM
Feb-28-24 05:30PM
04:42PM
04:10PM Loading…
04:10PM
04:05PM
Feb-22-24 05:45PM
Feb-21-24 05:50PM
04:05PM
07:00AM
Feb-15-24 05:45PM
08:50AM
Feb-07-24 05:45PM
Feb-06-24 09:30AM
Feb-05-24 09:55AM
Feb-02-24 05:50PM
Jan-30-24 08:50AM
Jan-19-24 09:55AM
Jan-17-24 09:30AM
08:50AM Loading…
Jan-10-24 08:50AM
Jan-08-24 07:00AM
Jan-05-24 12:00PM
Dec-26-23 09:30AM
Dec-25-23 09:55AM
Dec-18-23 04:05PM
Dec-12-23 07:00AM
Dec-08-23 09:30AM
Dec-06-23 09:40AM
Nov-22-23 09:30AM
Nov-17-23 06:29PM
Nov-16-23 07:00AM
Nov-10-23 11:05AM
Nov-09-23 04:25PM
10:04AM
Nov-08-23 04:49PM
04:05PM
Nov-06-23 09:30AM
Nov-02-23 05:45PM
Nov-01-23 07:00AM
Oct-27-23 05:45PM
Oct-25-23 05:50PM
Oct-17-23 05:50PM
Oct-09-23 05:50PM
Sep-29-23 09:30AM
Sep-27-23 05:50PM
Sep-21-23 05:50PM
Sep-14-23 05:50PM
Sep-13-23 09:30AM
Aug-10-23 02:31PM
11:50AM
09:40AM
06:46AM
Aug-09-23 06:40PM
05:37PM
04:05PM
Aug-02-23 07:00AM
Jul-28-23 08:59AM
Jul-26-23 11:30AM
Jul-25-23 05:12PM
Jul-20-23 05:50PM
Jul-19-23 07:00AM
Jul-13-23 05:50PM
Jul-07-23 07:32AM
Jun-23-23 10:31AM
Jun-22-23 09:18AM
Jun-21-23 03:21PM
10:46AM
Jun-19-23 10:28AM
Jun-16-23 10:43AM
10:26AM
Jun-14-23 12:17PM
11:48AM
09:40AM
Jun-13-23 09:18AM
Jun-08-23 11:49AM
11:20AM
Jun-07-23 12:31PM
Jun-06-23 11:14AM
Jun-05-23 12:43PM
10:22AM
Jun-02-23 10:59AM
Jun-01-23 11:59AM
May-31-23 10:46AM
May-30-23 10:56AM
May-29-23 09:40AM
May-26-23 08:23AM
May-25-23 03:16PM
May-24-23 11:37AM
08:14AM
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ELMS STEVEDirectorMar 19 '24Sale6.08411,8292,503,9202,115,671Mar 19 09:48 PM
ELMS STEVEDirectorMar 18 '24Sale6.0149,887299,8212,527,500Mar 19 09:48 PM
ELMS STEVEDirectorMar 15 '24Sale6.01183,0081,099,8782,577,387Mar 15 09:00 PM
ELMS STEVEDirectorMar 14 '24Sale6.05448,2762,712,0702,760,395Mar 15 09:00 PM
ELMS STEVEDirectorMar 13 '24Sale6.21407,0002,527,4703,208,671Mar 15 09:00 PM
Grossman Jerrold BDirectorAug 30 '23Buy3.71130,000482,144443,265Aug 30 04:58 PM
KWON YOUNGDirectorAug 24 '23Buy3.9025,00097,500277,401Aug 24 07:53 PM
Fong BryantDirectorAug 22 '23Sale3.871,433,3045,544,7370Aug 23 08:30 PM
Grossman Adam SPresident and CEOAug 18 '23Sale4.15250,0001,038,3502,273,085Aug 18 09:46 PM
LENZ BRIANEVP, CFOAug 16 '23Sale4.45178,184793,400782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 16 '23Sale4.383132,523,085Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15 '23Option Exercise3.112,100,4596,536,4484,623,544Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15 '23Option Exercise3.11809,2622,514,3631,591,275Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15 '23Sale4.54510,4692,318,9594,113,075Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15 '23Sale4.60211,578972,730782,013Aug 17 09:30 PM